Harrow Long Term Deferred Charges (Quarterly) Insights

Harrow, Inc. (HROW)

52.00 +1.18 (+2.32%) USD | NASDAQ | Feb 20, 16:00

52.03 +0.03 (+0.06%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for HROW.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	--
Assertio Holdings, Inc.	--
CapsoVision, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--